Inhibitory effect of Alantolactone against varicella-zoster virus in vitro
Open Access
- 9 May 2025
- journal article
- research article
- Published by Springer Nature in Virology Journal
- Vol. 22 (1) , 1-12
Abstract
Varicella-zoster virus (VZV), a member of the α-herpesvirus family, is known for causing two distinct diseases: chickenpox (varicella) during the primary infection and shingles (zoster) due to reactivation of the virus later in life. Although there are vaccines available to prevent VZV infection, it is still not universally effective, and antiviral treatments for VZV are limited and may come with significant side effects. Thus, development of novel therapeutics is urgently needed. We identified a naturally occurring Alantolactone (ALT) that inhibited replication of recombinant VZV in human diploid fibroblast (WI-38 cells) and Adult Retinal Pigment Epithelial cell line-19 (ARPE-19 cells) through Western blotting, qPCR and plaque assays. Subsequently, we explored the mechanism underlying the anti-VZV activity of ALT using time-of-addition experiments and transcriptomic analyses. A screening model was established for anti-VZV compounds, and we screened ALT was with good anti-VZV efficacy. Our findings revealed that ALT alleviated cytopathic changes, reduced viral titres, and inhibited the expression of viral genes and proteins in WI-38 cells and ARPE-19 cells. Furthermore, our data showed that ALT inhibited VZV infection in intracellular viral replication. Finally, multiple inflammatory pathways were involved in the antiviral role of ALT, and IL-6 was one of the most critical hub genes. Together, our findings identify ALT as an anti-VZV agent that may prove useful in the treatment of VZV replication.Keywords
Funding Information
- Hangzhou Health Science and Technology Plan (A20220018, ZD2022005)
- Key project joint construction by Science and Technology Department of National Administration of TCM and Zhejiang Administration of TCM (GZY-ZJ-KJ-23088, GZY-ZJ-KJ-24055)
This publication has 65 references indexed in Scilit:
- Inhibitory effects of baicalein against herpes simplex virus type 1Acta Pharmaceutica Sinica B, 2020
- Anti-varicella-zoster virus activity of cephalotaxine esters in vitroJournal of Microbiology, 2018
- 1,2,3,4,6-Penta-O-galloyl-ß-D-glucose, a bioactive compound in Elaeocarpus sylvestris extract, inhibits varicella-zoster virus replicationAntiviral Research, 2017
- Induction of varicella zoster virus DNA replication in dissociated human trigeminal gangliaJournal of NeuroVirology, 2016
- Alantolactone induces apoptosis in glioblastoma cells via GSH depletion, ROS generation, and mitochondrial dysfunctionIUBMB Life, 2012
- Antistaphylococcal activity of Inula helenium L. root essential oil: eudesmane sesquiterpene lactones induce cell membrane damageEuropean Journal of Clinical Microbiology & Infectious Diseases, 2011
- Inhibitory activity of oxyresveratrol on wild-type and drug-resistant varicella-zoster virus replication in vitroAntiviral Research, 2009
- Resveratrol inhibition of varicella-zoster virus replication in vitroAntiviral Research, 2006
- Fetal varicella syndrome: disruption of neural development and persistent inflammation of non-neural tissuesVirchows Archiv, 2000
- The glycoproteins of the human herpesvirusesComparative Immunology, Microbiology and Infectious Diseases, 1991